Temasek CEO: AI will have “profound impact” on pharma and biotech #shorts #bloomberginvest

How do you identify uh who's prone to it. Whether the software shock is really uh specific names that are going to go to zero and others that are going to be incredibly successful or some kind of widespread replacement. So I think you know with what we've seen the last few months um things that you didn't think would be disrupted are becoming disrupted or at least the perception of disruption is very high and so you now have to think about other things that you're investing in and what is the likelihood of ...